NCT04029337 - An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2030

Conditions

Mitral Regurgitation

Interventions

DEVICE

Transcatheter Mitral Valve Replacement

Minimally invasive transcatheter mitral valve implantation using the HighLife™ TMVR system

Trial Locations (10)

10467

RECRUITING

Montefiore Medical Center, New York

19104

TERMINATED

University of Pennsylvania, Philadelphia

23225

TERMINATED

Chippenham Hospital Richmond, Richmond

29425

RECRUITING

Medical University of South Carolina, Charleston

30309

RECRUITING

Piedmont Heart, Atlanta

55407

RECRUITING

Minneapolis Heart, Minneapolis

77030

RECRUITING

Houston Methodist Hospital, Houston

85712

RECRUITING

Tucson Medical Center, Tucson

91360

RECRUITING

Los Robles Regional Medical Center, Los Angeles

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors

lead

HighLife SAS

INDUSTRY